The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes
Open accessAbstract
High expression of IL-21 and/or IL-21R has been described in T cell-mediated inflammatory diseases characterized by defects of counterregulatory mechanisms. CD4+CD25+ regulatory T cells (Treg) are a T cell subset involved in the control of the immune responses. A diminished ability of these cells to inhibit T cell activation has been documented in immune-inflammatory diseases, raising the possibility that inflammatory stimuli can block the regulatory properties of Treg. We therefore examined whether IL-21 controls CD4+CD25+ T cell function. We demonstrate in this study that IL-21 markedly enhances the proliferation of human CD4+CD25− T cells and counteracts the suppressive activities of CD4+CD25+ T cells on CD4+CD25− T cells without affecting the percentage of Foxp3+ cells or survival of Treg. Additionally, CD4+CD25+ T cells induced in the presence of IL-21 maintain the ability to suppress alloresponses. Notably, IL-21 enhances the growth of CD8+CD25− T cells but does not revert the CD4+CD25+ T cell-mediated suppression of this cell type, indicating that IL-21 makes CD4+ T cells resistant to suppression rather than inhibiting CD4+CD25+ T cell activity. Finally, we show that IL-2, IL-7, and IL-15, but not IL-21, reverse the anergic phenotype of CD4+CD25+ T cells. Data indicate that IL-21 renders human CD4+CD25− T cells resistant to Treg-mediated suppression and suggest a novel mechanism by which IL-21 could augment T cell-activated responses in human immune-inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Inducing and expanding regulatory T cell populations by foreign antigen
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., & von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1265 · Cited by 1,241
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Self-citationZiegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
Piccirillo, C. A., & Shevach, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1137 · Cited by 716
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Control of T‐cell activation by CD4+ CD25+ suppressor T cells
Shevach, E. M., McHugh, R. S., Piccirillo, C. A., & Thornton, A. M. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820104.x · Cited by 546
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
Stephens, G. L., McHugh, R. S., Whitters, M. J., Young, D. A., Luxenberg, D., Carreno, B. M., Collins, M., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5008 · Cited by 499
Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation
Leonard, W. J., & Spolski, R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1688 · Cited by 441
Imbalance of regulatory T cells in human autoimmune diseases
Dejaco, C., Duftner, C., Grubeck‐Loebenstein, B., & Schirmer, M. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02317.x · Cited by 368
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Del Vecchio Blanco, G., Caruso, R., Tersigni, R., Alessandroni, L., Biancone, L., Naccari, G. C., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.042 · Cited by 293
Self-citationInterleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses
Parrish-Novak, J., Foster, D. C., Holly, R. D., & Clegg, C. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.856 · Cited by 256
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
Fehervari, Z. (2004) · International Immunology · doi:10.1093/intimm/dxh178 · Cited by 221
Jüngel, A., Distler, J. H. W., Kurowska‐Stolarska, M., Seemayer, C. A., Seibl, R., Forster, A., Michel, B. A., Gay, R. E., Emmrich, F., Gay, S., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20218 · Cited by 174
Skapenko, A., Kalden, J. R., Lipsky, P. E., & Schulze‐Koops, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6107 · Cited by 158
Expression of interleukin‐21 receptor in epidermis from patients with systemic sclerosis
Distler, J. H. W., Jüngel, A., Kowal‐Bielecka, O., Michel, B. A., Gay, R. E., Sprott, H., Matucci‐Cerinic, M., Chilla, M., Reich, K., Kalden, J. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20883 · Cited by 143
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
Vollmer, T. L., Liu, R., Price, M. A., Rhodes, S. N., Cava, A. L., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2696 · Cited by 137
Regulatory Cells and Infectious Agents: Detentes Cordiale and Contraire
Rouse, B. T., & Suvas, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2211 · Cited by 135
Comes, A., Rosso, O., Orengo, A. M., Carlo, E. D., Sorrentino, C., Meazza, R., Piazza, T., Valzasina, B., Nanni, P., Colombo, M. P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1750 · Cited by 107
In Vivo and In Vitro Roles of IL-21 in Inflammation
Pelletier, M., Bouchard, A., & Girard, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7521 · Cited by 107
Early Kinetic Window of Target T Cell Susceptibility to CD25+ Regulatory T Cell Activity
Sojka, D. K., Hughson, A. L., Sukiennicki, T. L., & Fowell, D. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7274 · Cited by 71
IL-21 and IL-21 Receptor: A New Cytokine Pathway Modulates Innate and Adaptive Immunity
Collins, M. A., Whitters, M. J., & Young, D. A. (2003) · Immunologic Research · doi:10.1385/ir:28:2:131 · Cited by 52
Cited by
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932
Advances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3212 · Cited by 880
Metadata
- Authors
- Peluso, I., Fantini, M. C., Fina, D., Caruso, R., Boirivant, M., MacDonald, T. T., Pallone, F., & Monteleone, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01
- Volume
- 178
- Issue
- 2
- Pages
- 732-739
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1564622887
- Cited by
- 285
- References
- 26
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.